An epidemiological study of hemodialysis patients based on the european fresenius medical care hemodialysis network: Results of the ARO study

Nephron - Clinical Practice

Volumn 118, Issue 2, 2011, Pages

  De Francisco, Angel L M ^a   Kim, Joseph ^b   Anker, Stefan D ^c,d   Belozeroff, Vasily ^e   Canaud, Bernard ^f   Chazot, Charles ^g   Drüeke, Tilman B ^h   Eckardt, Kai Uwe ⁱ   Floege, Jürgen ^j   Kronenberg, Florian ^k   MacDougall, Iain C ^l   Marcelli, Daniele ^b   Molemans, Bart ^m   Passlick Deetjen, Jutta ^b   Schernthaner, Guntram ⁿ   Stenvinkel, Peter ^o   Wheeler, David C ^d   Fouqueray, Bruno ^p   Aljama, Pedro ^q  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b AMGEN LTD   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d AMGEN INC   (United States)

^e LAPEYRONIE HOSPITAL   (France)

^f Centre de Rein Artificiel de Tassin   (France)

^g INSERM   (France)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁱ RWTH AACHEN UNIVERSITY   (Germany)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^k KING S COLLEGE HOSPITAL   (United Kingdom)

^l Fresenius Medical Care ^*  (Germany)

^m KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

^o ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^p HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^q IRCCS SAN RAFFAELE PISANA   (Italy)

more..

Author keywords

Anemia; Epidemiology; Hemodialysis; Mineral disorders; Mortality, practice patterns

Indexed keywords

PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CZECH REPUBLIC; EPIDEMIOLOGICAL DATA; EUROPE; FEMALE; FRANCE; HEALTH CARE FACILITY; HEMODIALYSIS; HUMAN; HUNGARY; ITALY; KIDNEY ARTERIOVENOUS FISTULA; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; POLAND; PORTUGAL; PRIORITY JOURNAL; SLOVAKIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; COHORT STUDIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 78649792845     PISSN: 16602110     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000319936     Document Type: Article

References (38)

1. Lameire N, Jager K, Van Biesen W, de Bacquer D, Vanholder R: Chronic kidney disease: A European perspective. Kidney Int Suppl 2005; 99:S30-S38.
2. Bommer J: Prevalence and socio-economic aspects of chronic kidney disease. Nephrol Dial Transplant 2002; 17(suppl 11):8-12. (Pubitemid 35277055)
3. Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW: Mortality among hemodialysis patients in Europe, Japan, and the United states: Case-mix effects. Am J Kidney Dis 2004; 44: 16-21.
4. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK: Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2004; 44: 305-316.
5. Port FK, Orzol SM, Held PJ, Wolfe RA: Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis 1998; 32:S34-S38.
6. Collins AJ, Brenner RM, Ofman JJ, Chi EM, Stuccio-White N, Krishnan M, Solid C, Ofsthun NJ, Lazarus JM: Epoetin alfa use in patients with ESRD: An analysis of recent US prescribing patterns and hemoglobin outcomes. Am J Kidney Dis 2005; 46: 481-488. (Pubitemid 41208184)
7. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218. (Pubitemid 39031360)
8. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277. (Pubitemid 37509303)
9. Lacson E Jr, Wang W, Hakim RM, Teng M, Lazarus JM: Associates of mortality and hospitalization in hemodialysis: Potentially actionable laboratory variables and vascular access. Am J Kidney Dis 2009; 53: 79-90.
10. Hecking E, Bragg-Gresham JL, Rayner HC, Pisoni RL, Andreucci VE, Combe C, Greenwood R, McCullough K, Feldman HI, Young EW, Held PJ, Port FK: Haemodialysis prescription, adherence and nutritional indicators in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 100-107. (Pubitemid 38072621)
11. Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piera L, Bragg-Gresham JL, Feldman HI, Goodkin DA, Gillespie B, Wolfe RA, Held PJ, Port FK: Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 108-120. (Pubitemid 38072622)
12. Locatelli F, Pisoni RL, Akizawa T, Cruz JM, Deoreo PB, Lameire NH, Held PJ: Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/ DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis 2004; 44: 27-33.
13. den Elzen WP, van Manen JG, Boeschoten EW, Krediet RT, Dekker FW: The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol Dial Transplant 2006; 21: 1588-1595. (Pubitemid 43834640)
14. Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, Tijssen JG, Krediet RT: Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1272-1279. (Pubitemid 32472642)
15. Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT: Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis 2000; 35: 69-79. (Pubitemid 30027243)
16. Fernández MJL, Ferreira A, Floege J, Bradbury BD, Benedik M, Pavlovic D, Verbeelen D, Nagy J, Motelln JL, Carter D, Locatelli F, Cannata-Anda JB, COSMOS Group: Results from the initial cross-sectional analysis of the COSMOS baseline population (abstract). Nephrol Dial Transplant 2006; 21 (suppl 4):MP358.
17. Marcelli D, Moscardo V, Steil H, Day M, Kirchgessner J, Mitteregger A, Orlandini G, Gatti E: Data management and quality assurance for dialysis network; in Ronco C, La Greca G (eds): Hemodialysis Technology. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 293-299.
18. Marcelli D, Kirchgessner J, Amato C, Steil H, Mitteregger A, Moscardo V, Carioni C, Orlandini G, Gatti E: EuClid (European Clinical Database): A database comparing different realities. J Nephrol 2001; 14(suppl 4):S94-S100. (Pubitemid 33743248)
19. Steil H, Amato C, Carioni C, Kirchgessner J, Marcelli D, Mitteregger A, Moscardo V, Orlandini G, Gatti E: EuClid - a medical registry. Methods Inf Med 2004; 43: 83-88.
20. Rothman KJ, Greenland S: Modern Epidemiology. Philadelphia, Lippincott-Raven, 1998.
21. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
22. Stel VS, Van Dijk PC, van Manen JG, Dekker FW, Ansell D, Conte F, Kramar R, Leivestad T, Vela E, Briggs JD, Jager KJ: Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant 2005; 20: 2803-2811. (Pubitemid 41672283)
23. Pisoni RL: Vascular access use and outcomes: Results from the DOPPS; in Ronco C, La Greca G (eds): Hemodialysis Technology. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 13-19.
24. Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ: High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 2004; 43: 1014-1023. (Pubitemid 38691496)
25. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007; 2: 89-99.
26. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG: Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865. (Pubitemid 44684819)
27. United States Renal Data System. 2004 Annual Data Reports: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004. http://www.usrds.org/atlas-2004.htm (accessed Feb 10, 2010).
28. Levi F, Lucchini F, Negri E, La VC: Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88: 119-124. (Pubitemid 34787755)
29. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2008; 23: 3219-3226.
30. Lacson E Jr, Wang W, Lazarus JM, Hakim RM: Hemodialysis facility-based quality-ofcare indicators and facility-specific patient outcomes. Am J Kidney Dis 2009; 54: 490-497.
31. Kalantar-Zadeh K, Lee GH, Miller JE, Streja E, Jing J, Robertson JA, Kovesdy CP: Predictors of hyporesponsiveness to erythropoiesis- stimulating agents in hemodialysis patients. Am J Kidney Dis 2009; 53: 823-834.
32. Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, Collart F, Kramar R, de Francisco A, Jager KJ: From registry data collection to international comparisons: Examples of haemodialysis duration and frequency. Nephrol Dial Transplant 2009; 24: 217-224.
33. Andreucci VE, Fissell RB, Bragg-Gresham JL, Ethier J, Greenwood R, Pauly M, Wizemann V, Port FK: Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients. Am J Kidney Dis 2004; 44: 61-67.
34. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248. (Pubitemid 41058323)
35. Fellstrom B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F: Cardiovascular disease in patients with renal disease: The role of statins. Curr Med Res Opin 2009; 25: 271-285.
36. Winkelmayer WC, Charytan DM, Levin R, Avorn J: Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis 2006; 47: 301-308. (Pubitemid 43121333)
37. Eckardt KU, Kim J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, Fouqueray B, Macdougall IC: Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol 2010; 21, in press.
38. Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC, ARO Investigators: Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2010 (E-pub ahead of print).